79 of 80 French Patients Prescribed Hydroxychloroquine Plus Z-PAC Recover

Political debate. Welcome Yahoo Message Board exiles and everybody else !!
Post Reply
User avatar
psk836
Get in my Belly!
Posts: 21386
Joined: Sat Sep 06, 2014 9:22 am

79 of 80 French Patients Prescribed Hydroxychloroquine Plus Z-PAC Recover

Post by psk836 » Fri Mar 27, 2020 10:14 pm

No control group. Severely ill patients. Publication should be this weekend.
1 x

User avatar
KC_
Rock Star
Posts: 12601
Joined: Sat Sep 08, 2018 2:46 pm

Re: 79 of 80 French Patients Prescribed Hydroxychloroquine Plus Z-PAC Recover

Post by KC_ » Fri Mar 27, 2020 10:17 pm

psk836 wrote:
Fri Mar 27, 2020 10:14 pm
No control group. Severely ill patients. Publication should be this weekend.
Very good news .
1 x
“I’d rather die standing up than live on my knees “
Stephane Charbonnier

User avatar
Chester Cheesewright
Majesty
Posts: 5339
Joined: Thu Sep 04, 2014 1:09 am

Re: 79 of 80 French Patients Prescribed Hydroxychloroquine Plus Z-PAC Recover

Post by Chester Cheesewright » Fri Mar 27, 2020 10:18 pm

psk836 wrote:
Fri Mar 27, 2020 10:14 pm
No control group. Severely ill patients. Publication should be this weekend.
► What if it turns out the President was just jiving?
0 x
And you know I started off in Brooklyn, my father gave me a small loan of a million dollars.” - -Donald Trump

User avatar
psk836
Get in my Belly!
Posts: 21386
Joined: Sat Sep 06, 2014 9:22 am

Re: 79 of 80 French Patients Prescribed Hydroxychloroquine Plus Z-PAC Recover

Post by psk836 » Sat Mar 28, 2020 5:13 pm

https://techstartups.com/2020/03/27/cor ... ficant-dr/

”Today, Prof. Didier Raoult and his team published results of their new study. The study was supported by the Institut Hospitalo-Universitaire (IHU) Méditerranée Infection. Unlike the previous small study trial, the new observation study has a larger sample size of 80 COVID-19 patients. The objective of the study was to find an effective treatment to cure COVID-19 patients and to decrease the virus carriage duration.
In 80 in-patients receiving a combination of hydroxychloroquine and azithromycin, the team found a clinical improvement in all but one 86 year-old patient who died, and one 74-year old patient still in intensive care unit. The team also found that, by administering hydroxychloroquine combined with azithromycin, they were able to observe an improvement in all cases, except in one patient who arrived with an advanced form, who was over the age of 86, and in whom the evolution was irreversible, according to a new paper published today in IHU Méditerranée Infection.
“For all other patients in the cohort of 80 people, the combination of hydroxychloroquine and azithromycin resulted in a clinical improvement that appeared significant when compared to the natural evolution in patients with a definite outcome, as described in the literature. In a cohort of 191 Chinese inpatients, of whom 95% received antibiotics and 21% received an association of lopinavir and ritonavir, the median duration of fever was 12 days and that of cough 19 days in survivors, with a 28% case-fatality rate (18),” the research team said.“
Last edited by psk836 on Sat Mar 28, 2020 5:16 pm, edited 1 time in total.
1 x

User avatar
DallasDimeBags
Imperial Majesty
Posts: 7506
Joined: Sat Sep 06, 2014 10:25 am

Re: 79 of 80 French Patients Prescribed Hydroxychloroquine Plus Z-PAC Recover

Post by DallasDimeBags » Sat Mar 28, 2020 5:15 pm

psk836 wrote:
Fri Mar 27, 2020 10:14 pm
No control group. Severely ill patients. Publication should be this weekend.
Encouraging news.
1 x

User avatar
psk836
Get in my Belly!
Posts: 21386
Joined: Sat Sep 06, 2014 9:22 am

Re: 79 of 80 French Patients Prescribed Hydroxychloroquine Plus Z-PAC Recover

Post by psk836 » Sat Mar 28, 2020 5:21 pm

“In conclusion, we confirm the efficacy of hydroxychloroquine associated with azithromycin in the treatment of COVID-19 and its potential effectiveness in the early impairment of contagiousness. Given the urgent therapeutic need to manage this disease with effective and safe drugs and given the negligible cost of both hydroxychloroquine and azithromycin, we believe that other teams should urgently evaluate this therapeutic strategy both to avoid the spread of the disease and to treat patients before severe irreversible respiratory complications take hold,” the team concluded.
March 28 Update: In a Twitter post day, Prof. Raoult said: “Our study concerns 80 patients, without a control group because we offer our protocol to all patients with no contraindication. This is what the Hippocratic Oath that we have taken dictates to us.”
1 x

Post Reply